Stocks
Health Care
qncx
Quince Therapeutics
NASDAQ: QNCX
-0.01 (-0.31%)
1.605
USD
At close at Sep 04, 20:40 UTC
Income Statement
Revenue
-
Gross Profit
-
Operating Income
-53.30M
Pretax Income
-60.61M
Net Income
-56.83M
EBITDA
-56.55M
EBIT
-56.74M
Earnings Per Share
-1.31
Balance Sheet
Cash & Cash Equivalents
9.65M
Total Debt
14.59M
Net Cash
20.86M
Net Cash Per Share
0.47
Equity (Book Value)
49.06M
Book Value Per Share
1.13
Working Capital
-
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.